Medical Grand Rounds - Pelvic Mass Risk Assessment: Is it a cancer?

Friday, September 25, 2020 | 12 p.m. - 1 p.m.
Microsoft Teams

E-mail Trish.Stern@guthrie.org
Sayre, PA 18840

Presenter: Richard G. Moore, MD, FACOG, FACS, Chief, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Director, Targeted Therapeutics Laboratory for Gynecologic Cancers, Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York

At the conclusion of this activity, participants should be able to:
  - Describe and understand the work-up of an ovarian cyst or pelvic mass.
  - Describe and understand the use of the Risk of Malignancy Algorithm.

Date:  Friday, September 25, 2020
Time: 12:00 p.m.
Location: Microsoft Teams - E-mail Trish.Stern@Guthrie.org to be included

This program is intended for: Physicians, Advanced Practice Providers, Fellows, Residents, Medical and Nursing Students, and other Ancillary Healthcare Professionals.

Accreditation Statement
“The Guthrie Clinic is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.”

Designation Statement
“The Guthrie Clinic designates this live activity for a maximum of (1.0) AMA PRA Category I Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.”

Disclosure/Conflict of Interest Statement
“Faculty and all others who have the ability to control  the content of continuing medical education activities sponsored by The Guthrie Clinic are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).” The presenting faculty has indicated that he may have a conflict of interest related directly or indirectly to his presentation. The presenter has indicated he receives consulting fees from Fujirebio Diagnostics. His presentation has been reviewed prior to today’s presentation by the MGR Program Director in which no commercial boas was perceived.